Vaxinnate
Cranbury, US · Delaware corporation · 1 known investors
Biotech
Founders & leadership
WP
Wayne PisanoExecutive
LT
Lynda TusseyExecutive
KA
Kathleen A. McGowanExecutive
PC
Philippe ChambonNamed on SEC filing
AR
Alan R. ShawNamed on SEC filing
SR
Seth RudnickNamed on SEC filing
AT
Andrew T. DrechslerNamed on SEC filing
Board
PO
Philippe O. ChambonBoard director
DW
David WilliamsBoard director
SW
Sam WuBoard director
AL
TS
Timothy ShannonBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$34.1M disclosed across 3 rounds · 2010–2015
▶$3.2MraisedSep 2015 · 14 investors · BiotechnologyRule 506(b)
▶$3.2MraisedSep 2015 · 14 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Philippe O. ChambonDirector
- Thomas MonathDirector
- Wayne PisanoExecutive Officer, Director
- David WilliamsDirector
- Sam WuDirector
- Augustine LawlorDirector
- Lynda TusseyExecutive Officer
- Kathleen A. McGowanExecutive Officer
- Timothy ShannonDirector
- Offering amount
- $4.3M
- Amount sold
- $3.2M
- First sale
- Sep 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6MraisedOct 2014 · 9 investors · BiotechnologyRule 506(b)
▶$6MraisedOct 2014 · 9 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Seth RudnickDirector
- Wayne PisanoExecutive Officer, Director
- David WilliamsDirector
- Kathleen A. McGowanExecutive Officer
- Augustine LawlorDirector
- Sam WuDirector
- Phillippe O. ChambonDirector
- Offering amount
- $6.3M
- Amount sold
- $6M
- First sale
- Sep 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$24.8MraisedFeb 2012 · 13 investors · BiotechnologyRule 506(b)
▶$24.8MraisedFeb 2012 · 13 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Philippe ChambonDirector
- Alan R. ShawExecutive Officer, Director
- Augustine LawlorDirector
- David WilliamsDirector
- Sam WuDirector
- Seth RudnickDirector
- Andrew T. DrechslerExecutive Officer
- Offering amount
- $25M
- Amount sold
- $24.8M
- First sale
- Mar 2010
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Vaxinnate's investors?
- Vaxinnate's investors include HealthCare Ventures, LLC.
- How much funding has Vaxinnate raised?
- Vaxinnate has disclosed $34.1M raised across 3 rounds.
- Where is Vaxinnate headquartered?
- Vaxinnate is headquartered in Cranbury, US.